nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—CYP3A4—type 2 diabetes mellitus	0.121	0.534	CbGaD
Vismodegib—ALB—type 2 diabetes mellitus	0.106	0.466	CbGaD
Vismodegib—ORM1—Nateglinide—type 2 diabetes mellitus	0.0344	0.0617	CbGbCtD
Vismodegib—ALB—Gliclazide—type 2 diabetes mellitus	0.0225	0.0403	CbGbCtD
Vismodegib—ALB—Repaglinide—type 2 diabetes mellitus	0.0211	0.0379	CbGbCtD
Vismodegib—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0204	0.0366	CbGbCtD
Vismodegib—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0176	0.0316	CbGbCtD
Vismodegib—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0163	0.0293	CbGbCtD
Vismodegib—ALB—Valsartan—type 2 diabetes mellitus	0.0156	0.0279	CbGbCtD
Vismodegib—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0155	0.0278	CbGbCtD
Vismodegib—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0148	0.0265	CbGbCtD
Vismodegib—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0146	0.0261	CbGbCtD
Vismodegib—ALB—Nateglinide—type 2 diabetes mellitus	0.0145	0.026	CbGbCtD
Vismodegib—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0143	0.0255	CbGbCtD
Vismodegib—ABCG2—Glyburide—type 2 diabetes mellitus	0.0142	0.0254	CbGbCtD
Vismodegib—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0138	0.0248	CbGbCtD
Vismodegib—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0136	0.0244	CbGbCtD
Vismodegib—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0132	0.0236	CbGbCtD
Vismodegib—CYP2C9—Glipizide—type 2 diabetes mellitus	0.013	0.0234	CbGbCtD
Vismodegib—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0124	0.0222	CbGbCtD
Vismodegib—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0124	0.0222	CbGbCtD
Vismodegib—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0121	0.0217	CbGbCtD
Vismodegib—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0114	0.0205	CbGbCtD
Vismodegib—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.011	0.0198	CbGbCtD
Vismodegib—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0107	0.0192	CbGbCtD
Vismodegib—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0185	CbGbCtD
Vismodegib—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0103	0.0185	CbGbCtD
Vismodegib—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.01	0.0179	CbGbCtD
Vismodegib—ALB—Glyburide—type 2 diabetes mellitus	0.00979	0.0175	CbGbCtD
Vismodegib—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00951	0.017	CbGbCtD
Vismodegib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0093	0.0167	CbGbCtD
Vismodegib—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00919	0.0165	CbGbCtD
Vismodegib—ALB—Losartan—type 2 diabetes mellitus	0.00895	0.016	CbGbCtD
Vismodegib—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0084	0.015	CbGbCtD
Vismodegib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00829	0.0148	CbGbCtD
Vismodegib—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00781	0.014	CbGbCtD
Vismodegib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00758	0.0136	CbGbCtD
Vismodegib—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00749	0.0134	CbGbCtD
Vismodegib—CYP2C8—Losartan—type 2 diabetes mellitus	0.00692	0.0124	CbGbCtD
Vismodegib—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00687	0.0123	CbGbCtD
Vismodegib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00663	0.0119	CbGbCtD
Vismodegib—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00635	0.0114	CbGbCtD
Vismodegib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00599	0.0107	CbGbCtD
Vismodegib—CYP2C19—Losartan—type 2 diabetes mellitus	0.0058	0.0104	CbGbCtD
Vismodegib—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00528	0.00945	CbGbCtD
Vismodegib—ABCB1—Glyburide—type 2 diabetes mellitus	0.00512	0.00917	CbGbCtD
Vismodegib—CYP2C9—Losartan—type 2 diabetes mellitus	0.00483	0.00864	CbGbCtD
Vismodegib—ABCB1—Losartan—type 2 diabetes mellitus	0.00468	0.00839	CbGbCtD
Vismodegib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00454	0.00814	CbGbCtD
Vismodegib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00435	0.0078	CbGbCtD
Vismodegib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00435	0.0078	CbGbCtD
Vismodegib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00412	0.00738	CbGbCtD
Vismodegib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00307	0.0055	CbGbCtD
Vismodegib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00281	0.00503	CbGbCtD
Vismodegib—Etoricoxib—CYP2E1—type 2 diabetes mellitus	0.000415	0.118	CrCbGaD
Vismodegib—Etoricoxib—CYP1A2—type 2 diabetes mellitus	0.000395	0.112	CrCbGaD
Vismodegib—Sulfasalazine—PPARG—type 2 diabetes mellitus	0.000358	0.102	CrCbGaD
Vismodegib—Sulfasalazine—ABCC2—type 2 diabetes mellitus	0.000349	0.0992	CrCbGaD
Vismodegib—Tolvaptan—CYP3A4—type 2 diabetes mellitus	0.000345	0.0982	CrCbGaD
Vismodegib—Sorafenib—ABCC2—type 2 diabetes mellitus	0.000329	0.0936	CrCbGaD
Vismodegib—Sorafenib—HTR2C—type 2 diabetes mellitus	0.000291	0.0828	CrCbGaD
Vismodegib—Etoricoxib—CYP3A4—type 2 diabetes mellitus	0.000262	0.0744	CrCbGaD
Vismodegib—Etoricoxib—PTGS2—type 2 diabetes mellitus	0.000256	0.0728	CrCbGaD
Vismodegib—Nausea—Nateglinide—type 2 diabetes mellitus	0.00025	0.00208	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000249	0.00207	CcSEcCtD
Vismodegib—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000249	0.00207	CcSEcCtD
Vismodegib—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000249	0.00207	CcSEcCtD
Vismodegib—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00207	CcSEcCtD
Vismodegib—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000248	0.00206	CcSEcCtD
Vismodegib—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Back pain—Gliclazide—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000247	0.00205	CcSEcCtD
Vismodegib—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000245	0.00203	CcSEcCtD
Vismodegib—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000244	0.00203	CcSEcCtD
Vismodegib—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00202	CcSEcCtD
Vismodegib—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.00202	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000243	0.00202	CcSEcCtD
Vismodegib—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000243	0.00201	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000242	0.00201	CcSEcCtD
Vismodegib—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000242	0.00201	CcSEcCtD
Vismodegib—Myalgia—Glyburide—type 2 diabetes mellitus	0.000242	0.00201	CcSEcCtD
Vismodegib—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000242	0.00201	CcSEcCtD
Vismodegib—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000241	0.002	CcSEcCtD
Vismodegib—Pain—Sitagliptin—type 2 diabetes mellitus	0.00024	0.00199	CcSEcCtD
Vismodegib—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00024	0.00199	CcSEcCtD
Vismodegib—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000238	0.00198	CcSEcCtD
Vismodegib—Alopecia—Valsartan—type 2 diabetes mellitus	0.000238	0.00198	CcSEcCtD
Vismodegib—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000236	0.00196	CcSEcCtD
Vismodegib—Alopecia—Orlistat—type 2 diabetes mellitus	0.000235	0.00195	CcSEcCtD
Vismodegib—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000235	0.00195	CcSEcCtD
Vismodegib—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000232	0.00192	CcSEcCtD
Vismodegib—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000232	0.00192	CcSEcCtD
Vismodegib—SHH—kidney—type 2 diabetes mellitus	0.000231	0.157	CbGeAlD
Vismodegib—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00023	0.00191	CcSEcCtD
Vismodegib—Rash—Repaglinide—type 2 diabetes mellitus	0.00023	0.00191	CcSEcCtD
Vismodegib—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.00023	0.00191	CcSEcCtD
Vismodegib—SHH—pancreas—type 2 diabetes mellitus	0.00023	0.156	CbGeAlD
Vismodegib—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00023	0.00191	CcSEcCtD
Vismodegib—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000229	0.0019	CcSEcCtD
Vismodegib—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000228	0.00189	CcSEcCtD
Vismodegib—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000228	0.00189	CcSEcCtD
Vismodegib—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000227	0.00188	CcSEcCtD
Vismodegib—Back pain—Valsartan—type 2 diabetes mellitus	0.000227	0.00188	CcSEcCtD
Vismodegib—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000226	0.00187	CcSEcCtD
Vismodegib—Back pain—Orlistat—type 2 diabetes mellitus	0.000224	0.00186	CcSEcCtD
Vismodegib—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00186	CcSEcCtD
Vismodegib—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000223	0.00185	CcSEcCtD
Vismodegib—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000222	0.00185	CcSEcCtD
Vismodegib—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00184	CcSEcCtD
Vismodegib—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00183	CcSEcCtD
Vismodegib—Sorafenib—CYP1A2—type 2 diabetes mellitus	0.00022	0.0625	CrCbGaD
Vismodegib—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000219	0.00182	CcSEcCtD
Vismodegib—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000219	0.00182	CcSEcCtD
Vismodegib—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000217	0.0018	CcSEcCtD
Vismodegib—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000217	0.0018	CcSEcCtD
Vismodegib—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000217	0.0018	CcSEcCtD
Vismodegib—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000217	0.0018	CcSEcCtD
Vismodegib—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000217	0.0018	CcSEcCtD
Vismodegib—Nausea—Repaglinide—type 2 diabetes mellitus	0.000216	0.0018	CcSEcCtD
Vismodegib—Asthenia—Glipizide—type 2 diabetes mellitus	0.000216	0.0018	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000216	0.00179	CcSEcCtD
Vismodegib—Malnutrition—Metformin—type 2 diabetes mellitus	0.000214	0.00177	CcSEcCtD
Vismodegib—Pruritus—Glipizide—type 2 diabetes mellitus	0.000213	0.00177	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000211	0.00176	CcSEcCtD
Vismodegib—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000209	0.00174	CcSEcCtD
Vismodegib—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00172	CcSEcCtD
Vismodegib—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000207	0.00172	CcSEcCtD
Vismodegib—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000206	0.00171	CcSEcCtD
Vismodegib—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000205	0.00171	CcSEcCtD
Vismodegib—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000205	0.0017	CcSEcCtD
Vismodegib—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000204	0.0017	CcSEcCtD
Vismodegib—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000204	0.0017	CcSEcCtD
Vismodegib—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000202	0.00168	CcSEcCtD
Vismodegib—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000202	0.00168	CcSEcCtD
Vismodegib—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000202	0.00167	CcSEcCtD
Vismodegib—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000202	0.00167	CcSEcCtD
Vismodegib—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00167	CcSEcCtD
Vismodegib—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00167	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.0002	0.00166	CcSEcCtD
Vismodegib—Myalgia—Valsartan—type 2 diabetes mellitus	0.0002	0.00166	CcSEcCtD
Vismodegib—Arthralgia—Valsartan—type 2 diabetes mellitus	0.0002	0.00166	CcSEcCtD
Vismodegib—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000199	0.00165	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000198	0.00165	CcSEcCtD
Vismodegib—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000198	0.00164	CcSEcCtD
Vismodegib—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000197	0.00164	CcSEcCtD
Vismodegib—Myalgia—Orlistat—type 2 diabetes mellitus	0.000197	0.00164	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000196	0.00163	CcSEcCtD
Vismodegib—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000194	0.00161	CcSEcCtD
Vismodegib—Alopecia—Losartan—type 2 diabetes mellitus	0.000193	0.0016	CcSEcCtD
Vismodegib—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000193	0.0016	CcSEcCtD
Vismodegib—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000192	0.00159	CcSEcCtD
Vismodegib—Vomiting—Glipizide—type 2 diabetes mellitus	0.000192	0.00159	CcSEcCtD
Vismodegib—Rash—Glipizide—type 2 diabetes mellitus	0.00019	0.00158	CcSEcCtD
Vismodegib—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00019	0.00158	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00019	0.00158	CcSEcCtD
Vismodegib—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00019	0.00158	CcSEcCtD
Vismodegib—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000188	0.00156	CcSEcCtD
Vismodegib—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000186	0.00154	CcSEcCtD
Vismodegib—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000186	0.00154	CcSEcCtD
Vismodegib—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000185	0.00154	CcSEcCtD
Vismodegib—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000184	0.00153	CcSEcCtD
Vismodegib—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000184	0.00152	CcSEcCtD
Vismodegib—Back pain—Losartan—type 2 diabetes mellitus	0.000183	0.00152	CcSEcCtD
Vismodegib—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000183	0.00152	CcSEcCtD
Vismodegib—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000183	0.00152	CcSEcCtD
Vismodegib—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000182	0.00151	CcSEcCtD
Vismodegib—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00151	CcSEcCtD
Vismodegib—Myalgia—Metformin—type 2 diabetes mellitus	0.000182	0.00151	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000181	0.0015	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00018	0.00149	CcSEcCtD
Vismodegib—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00018	0.00149	CcSEcCtD
Vismodegib—Nausea—Glipizide—type 2 diabetes mellitus	0.000179	0.00149	CcSEcCtD
Vismodegib—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000179	0.00149	CcSEcCtD
Vismodegib—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000178	0.00148	CcSEcCtD
Vismodegib—Pain—Gliclazide—type 2 diabetes mellitus	0.000178	0.00148	CcSEcCtD
Vismodegib—Constipation—Gliclazide—type 2 diabetes mellitus	0.000178	0.00148	CcSEcCtD
Vismodegib—Rash—Glimepiride—type 2 diabetes mellitus	0.000177	0.00147	CcSEcCtD
Vismodegib—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000177	0.00147	CcSEcCtD
Vismodegib—Rash—Sitagliptin—type 2 diabetes mellitus	0.000177	0.00147	CcSEcCtD
Vismodegib—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000177	0.00147	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000174	0.00145	CcSEcCtD
Vismodegib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000174	0.00144	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000172	0.00143	CcSEcCtD
Vismodegib—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000172	0.00142	CcSEcCtD
Vismodegib—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000172	0.00142	CcSEcCtD
Vismodegib—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000171	0.00142	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00017	0.00142	CcSEcCtD
Vismodegib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00017	0.00141	CcSEcCtD
Vismodegib—Skin disorder—Metformin—type 2 diabetes mellitus	0.000169	0.00141	CcSEcCtD
Vismodegib—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000169	0.0014	CcSEcCtD
Vismodegib—Nausea—Glimepiride—type 2 diabetes mellitus	0.000167	0.00139	CcSEcCtD
Vismodegib—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00138	CcSEcCtD
Vismodegib—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000167	0.00138	CcSEcCtD
Vismodegib—Asthenia—Glyburide—type 2 diabetes mellitus	0.000166	0.00138	CcSEcCtD
Vismodegib—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000166	0.00138	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000165	0.00137	CcSEcCtD
Vismodegib—Alopecia—Ramipril—type 2 diabetes mellitus	0.000165	0.00137	CcSEcCtD
Vismodegib—Fatigue—Valsartan—type 2 diabetes mellitus	0.000165	0.00137	CcSEcCtD
Vismodegib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000165	0.00137	CcSEcCtD
Vismodegib—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000164	0.00137	CcSEcCtD
Vismodegib—Pruritus—Glyburide—type 2 diabetes mellitus	0.000164	0.00136	CcSEcCtD
Vismodegib—Constipation—Valsartan—type 2 diabetes mellitus	0.000164	0.00136	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000163	0.00136	CcSEcCtD
Vismodegib—Fatigue—Orlistat—type 2 diabetes mellitus	0.000163	0.00135	CcSEcCtD
Vismodegib—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000163	0.00135	CcSEcCtD
Vismodegib—Pain—Orlistat—type 2 diabetes mellitus	0.000162	0.00134	CcSEcCtD
Vismodegib—Myalgia—Losartan—type 2 diabetes mellitus	0.000161	0.00134	CcSEcCtD
Vismodegib—Arthralgia—Losartan—type 2 diabetes mellitus	0.000161	0.00134	CcSEcCtD
Vismodegib—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00134	CcSEcCtD
Vismodegib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000161	0.00134	CcSEcCtD
Vismodegib—Rash—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00133	CcSEcCtD
Vismodegib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00133	CcSEcCtD
Vismodegib—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00016	0.00133	CcSEcCtD
Vismodegib—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000159	0.00132	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000159	0.00132	CcSEcCtD
Vismodegib—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000159	0.00132	CcSEcCtD
Vismodegib—SMO—cortex of kidney—type 2 diabetes mellitus	0.000157	0.107	CbGeAlD
Vismodegib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000157	0.0013	CcSEcCtD
Vismodegib—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000156	0.0013	CcSEcCtD
Vismodegib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000155	0.00128	CcSEcCtD
Vismodegib—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000153	0.00127	CcSEcCtD
Vismodegib—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000152	0.00126	CcSEcCtD
Vismodegib—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000152	0.00126	CcSEcCtD
Vismodegib—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000151	0.00126	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—type 2 diabetes mellitus	0.000151	0.0429	CrCbGaD
Vismodegib—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00125	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00015	0.00125	CcSEcCtD
Vismodegib—Fatigue—Metformin—type 2 diabetes mellitus	0.00015	0.00125	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00015	0.00124	CcSEcCtD
Vismodegib—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00015	0.00124	CcSEcCtD
Vismodegib—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000149	0.00124	CcSEcCtD
Vismodegib—Constipation—Metformin—type 2 diabetes mellitus	0.000149	0.00124	CcSEcCtD
Vismodegib—Vomiting—Glyburide—type 2 diabetes mellitus	0.000148	0.00122	CcSEcCtD
Vismodegib—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000147	0.00122	CcSEcCtD
Vismodegib—Rash—Glyburide—type 2 diabetes mellitus	0.000146	0.00121	CcSEcCtD
Vismodegib—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000146	0.00121	CcSEcCtD
Vismodegib—SMO—adipose tissue—type 2 diabetes mellitus	0.000146	0.099	CbGeAlD
Vismodegib—Sorafenib—CYP3A4—type 2 diabetes mellitus	0.000146	0.0414	CrCbGaD
Vismodegib—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000145	0.0012	CcSEcCtD
Vismodegib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000143	0.00119	CcSEcCtD
Vismodegib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000143	0.00118	CcSEcCtD
Vismodegib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000143	0.00118	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000142	0.00118	CcSEcCtD
Vismodegib—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000142	0.00118	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000141	0.00117	CcSEcCtD
Vismodegib—Pain—Irbesartan—type 2 diabetes mellitus	0.000141	0.00117	CcSEcCtD
Vismodegib—Constipation—Irbesartan—type 2 diabetes mellitus	0.000141	0.00117	CcSEcCtD
Vismodegib—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000138	0.00115	CcSEcCtD
Vismodegib—Myalgia—Ramipril—type 2 diabetes mellitus	0.000138	0.00115	CcSEcCtD
Vismodegib—Nausea—Glyburide—type 2 diabetes mellitus	0.000138	0.00114	CcSEcCtD
Vismodegib—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000138	0.00114	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000138	0.00114	CcSEcCtD
Vismodegib—Asthenia—Valsartan—type 2 diabetes mellitus	0.000137	0.00114	CcSEcCtD
Vismodegib—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000136	0.00113	CcSEcCtD
Vismodegib—Asthenia—Orlistat—type 2 diabetes mellitus	0.000136	0.00113	CcSEcCtD
Vismodegib—Pruritus—Valsartan—type 2 diabetes mellitus	0.000135	0.00112	CcSEcCtD
Vismodegib—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000135	0.00112	CcSEcCtD
Vismodegib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000135	0.00112	CcSEcCtD
Vismodegib—Pruritus—Orlistat—type 2 diabetes mellitus	0.000134	0.00111	CcSEcCtD
Vismodegib—Fatigue—Losartan—type 2 diabetes mellitus	0.000133	0.00111	CcSEcCtD
Vismodegib—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000132	0.0011	CcSEcCtD
Vismodegib—Pain—Losartan—type 2 diabetes mellitus	0.000132	0.0011	CcSEcCtD
Vismodegib—Constipation—Losartan—type 2 diabetes mellitus	0.000132	0.0011	CcSEcCtD
Vismodegib—Rash—Gliclazide—type 2 diabetes mellitus	0.000131	0.00109	CcSEcCtD
Vismodegib—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000131	0.00109	CcSEcCtD
Vismodegib—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000131	0.00109	CcSEcCtD
Vismodegib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00013	0.00108	CcSEcCtD
Vismodegib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00013	0.00108	CcSEcCtD
Vismodegib—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000129	0.00107	CcSEcCtD
Vismodegib—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000129	0.00107	CcSEcCtD
Vismodegib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000127	0.00105	CcSEcCtD
Vismodegib—Asthenia—Metformin—type 2 diabetes mellitus	0.000125	0.00104	CcSEcCtD
Vismodegib—Nausea—Gliclazide—type 2 diabetes mellitus	0.000124	0.00103	CcSEcCtD
Vismodegib—Pruritus—Metformin—type 2 diabetes mellitus	0.000123	0.00102	CcSEcCtD
Vismodegib—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000122	0.00102	CcSEcCtD
Vismodegib—Vomiting—Valsartan—type 2 diabetes mellitus	0.000122	0.00101	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000121	0.001	CcSEcCtD
Vismodegib—Rash—Valsartan—type 2 diabetes mellitus	0.000121	0.001	CcSEcCtD
Vismodegib—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000121	0.001	CcSEcCtD
Vismodegib—Vomiting—Orlistat—type 2 diabetes mellitus	0.00012	0.000999	CcSEcCtD
Vismodegib—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000119	0.00099	CcSEcCtD
Vismodegib—Rash—Orlistat—type 2 diabetes mellitus	0.000119	0.00099	CcSEcCtD
Vismodegib—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000119	0.000989	CcSEcCtD
Vismodegib—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00098	CcSEcCtD
Vismodegib—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000117	0.00097	CcSEcCtD
Vismodegib—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000116	0.000966	CcSEcCtD
Vismodegib—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000115	0.000958	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000952	CcSEcCtD
Vismodegib—Fatigue—Ramipril—type 2 diabetes mellitus	0.000114	0.00095	CcSEcCtD
Vismodegib—Nausea—Valsartan—type 2 diabetes mellitus	0.000114	0.000944	CcSEcCtD
Vismodegib—Constipation—Ramipril—type 2 diabetes mellitus	0.000114	0.000943	CcSEcCtD
Vismodegib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000113	0.000935	CcSEcCtD
Vismodegib—Nausea—Orlistat—type 2 diabetes mellitus	0.000112	0.000933	CcSEcCtD
Vismodegib—Asthenia—Losartan—type 2 diabetes mellitus	0.000111	0.000922	CcSEcCtD
Vismodegib—Vomiting—Metformin—type 2 diabetes mellitus	0.000111	0.00092	CcSEcCtD
Vismodegib—Rash—Metformin—type 2 diabetes mellitus	0.00011	0.000913	CcSEcCtD
Vismodegib—Dermatitis—Metformin—type 2 diabetes mellitus	0.00011	0.000912	CcSEcCtD
Vismodegib—Pruritus—Losartan—type 2 diabetes mellitus	0.00011	0.000909	CcSEcCtD
Vismodegib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000109	0.000901	CcSEcCtD
Vismodegib—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000106	0.00088	CcSEcCtD
Vismodegib—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000105	0.000871	CcSEcCtD
Vismodegib—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000105	0.000868	CcSEcCtD
Vismodegib—Rash—Irbesartan—type 2 diabetes mellitus	0.000104	0.000861	CcSEcCtD
Vismodegib—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000104	0.00086	CcSEcCtD
Vismodegib—Nausea—Metformin—type 2 diabetes mellitus	0.000104	0.00086	CcSEcCtD
Vismodegib—SMO—liver—type 2 diabetes mellitus	0.000102	0.0694	CbGeAlD
Vismodegib—Vomiting—Losartan—type 2 diabetes mellitus	9.84e-05	0.000817	CcSEcCtD
Vismodegib—Nausea—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000811	CcSEcCtD
Vismodegib—Rash—Losartan—type 2 diabetes mellitus	9.76e-05	0.00081	CcSEcCtD
Vismodegib—Dermatitis—Losartan—type 2 diabetes mellitus	9.75e-05	0.00081	CcSEcCtD
Vismodegib—Asthenia—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000791	CcSEcCtD
Vismodegib—Pruritus—Ramipril—type 2 diabetes mellitus	9.39e-05	0.00078	CcSEcCtD
Vismodegib—Nausea—Losartan—type 2 diabetes mellitus	9.2e-05	0.000764	CcSEcCtD
Vismodegib—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.08e-05	0.000754	CcSEcCtD
Vismodegib—Vomiting—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000701	CcSEcCtD
Vismodegib—Rash—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000695	CcSEcCtD
Vismodegib—Dermatitis—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000694	CcSEcCtD
Vismodegib—Nausea—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000655	CcSEcCtD
Vismodegib—ABCG2—nephron tubule—type 2 diabetes mellitus	4.82e-05	0.0327	CbGeAlD
Vismodegib—ORM1—liver—type 2 diabetes mellitus	4.47e-05	0.0303	CbGeAlD
Vismodegib—CYP2C8—kidney—type 2 diabetes mellitus	4.35e-05	0.0296	CbGeAlD
Vismodegib—CYP2C9—cardiovascular system—type 2 diabetes mellitus	3.95e-05	0.0269	CbGeAlD
Vismodegib—ALB—liver—type 2 diabetes mellitus	3.92e-05	0.0266	CbGeAlD
Vismodegib—ABCG2—adipose tissue—type 2 diabetes mellitus	3.82e-05	0.0259	CbGeAlD
Vismodegib—CYP2C19—liver—type 2 diabetes mellitus	3.15e-05	0.0214	CbGeAlD
Vismodegib—ABCB1—islet of Langerhans—type 2 diabetes mellitus	2.95e-05	0.02	CbGeAlD
Vismodegib—CYP3A4—kidney—type 2 diabetes mellitus	2.95e-05	0.02	CbGeAlD
Vismodegib—CYP2C8—liver—type 2 diabetes mellitus	2.75e-05	0.0187	CbGeAlD
Vismodegib—ABCG2—liver—type 2 diabetes mellitus	2.68e-05	0.0182	CbGeAlD
Vismodegib—ABCB1—retina—type 2 diabetes mellitus	2.52e-05	0.0171	CbGeAlD
Vismodegib—CYP2C9—liver—type 2 diabetes mellitus	2.45e-05	0.0166	CbGeAlD
Vismodegib—ABCB1—nephron tubule—type 2 diabetes mellitus	2.38e-05	0.0161	CbGeAlD
Vismodegib—ABCB1—cardiovascular system—type 2 diabetes mellitus	2.13e-05	0.0145	CbGeAlD
Vismodegib—ABCB1—kidney—type 2 diabetes mellitus	2.09e-05	0.0142	CbGeAlD
Vismodegib—ABCB1—pancreas—type 2 diabetes mellitus	2.07e-05	0.0141	CbGeAlD
Vismodegib—ABCB1—cortex of kidney—type 2 diabetes mellitus	2.03e-05	0.0138	CbGeAlD
Vismodegib—ABCB1—adipose tissue—type 2 diabetes mellitus	1.88e-05	0.0128	CbGeAlD
Vismodegib—CYP3A4—liver—type 2 diabetes mellitus	1.86e-05	0.0127	CbGeAlD
Vismodegib—ABCB1—liver—type 2 diabetes mellitus	1.32e-05	0.00897	CbGeAlD
Vismodegib—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	4.73e-06	5.29e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.72e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	4.72e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	4.72e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	4.72e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	4.71e-06	5.26e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	4.71e-06	5.26e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	4.69e-06	5.25e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.69e-06	5.25e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	4.68e-06	5.23e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	4.68e-06	5.23e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.66e-06	5.21e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.65e-06	5.2e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.65e-06	5.2e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.65e-06	5.2e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.61e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.61e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.61e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.61e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	4.59e-06	5.13e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.57e-06	5.11e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.56e-06	5.1e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.56e-06	5.1e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.56e-06	5.1e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.54e-06	5.08e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.53e-06	5.07e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.53e-06	5.07e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.53e-06	5.07e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.52e-06	5.05e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	4.51e-06	5.05e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.51e-06	5.05e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.49e-06	5.02e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.49e-06	5.02e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.46e-06	4.98e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.45e-06	4.98e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.42e-06	4.95e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.41e-06	4.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.34e-06	4.85e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.32e-06	4.84e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.32e-06	4.83e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.25e-06	4.75e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.25e-06	4.75e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.24e-06	4.74e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.24e-06	4.74e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.24e-06	4.74e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.2e-06	4.7e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.2e-06	4.7e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.17e-06	4.66e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.16e-06	4.65e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.15e-06	4.64e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.12e-06	4.61e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.1e-06	4.59e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.1e-06	4.59e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.1e-06	4.58e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.09e-06	4.57e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.08e-06	4.56e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.06e-06	4.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.06e-06	4.54e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.03e-06	4.51e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.03e-06	4.51e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.03e-06	4.5e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.03e-06	4.5e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4e-06	4.47e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.93e-06	4.4e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.93e-06	4.4e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	3.93e-06	4.39e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.92e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.92e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.92e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.92e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.89e-06	4.35e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.89e-06	4.35e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	4.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.87e-06	4.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNB3—type 2 diabetes mellitus	3.87e-06	4.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.87e-06	4.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	3.85e-06	4.31e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.83e-06	4.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.83e-06	4.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.82e-06	4.27e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.8e-06	4.25e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.76e-06	4.2e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	3.75e-06	4.19e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.74e-06	4.18e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.72e-06	4.16e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.71e-06	4.15e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.69e-06	4.12e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.67e-06	4.11e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.67e-06	4.11e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.61e-06	4.03e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.61e-06	4.03e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.59e-06	4.01e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.58e-06	4.01e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	3.58e-06	4.01e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.54e-06	3.96e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.52e-06	3.94e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.49e-06	3.91e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.47e-06	3.88e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.47e-06	3.88e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.47e-06	3.88e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.46e-06	3.87e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.45e-06	3.86e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.45e-06	3.86e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.44e-06	3.84e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.41e-06	3.81e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.39e-06	3.79e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.39e-06	3.79e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.37e-06	3.77e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.36e-06	3.76e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.35e-06	3.74e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.33e-06	3.72e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.32e-06	3.72e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.31e-06	3.7e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.3e-06	3.69e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.28e-06	3.67e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.26e-06	3.65e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.23e-06	3.61e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.22e-06	3.6e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.2e-06	3.57e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.2e-06	3.57e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.19e-06	3.57e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.17e-06	3.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.17e-06	3.54e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.17e-06	3.54e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.16e-06	3.54e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.15e-06	3.52e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.14e-06	3.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.13e-06	3.51e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.13e-06	3.5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.11e-06	3.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.11e-06	3.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.11e-06	3.48e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.11e-06	3.48e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.11e-06	3.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.1e-06	3.46e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.09e-06	3.46e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.09e-06	3.45e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.08e-06	3.45e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.04e-06	3.4e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.03e-06	3.39e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.02e-06	3.38e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.02e-06	3.38e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.01e-06	3.37e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.01e-06	3.37e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3e-06	3.36e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3e-06	3.36e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.98e-06	3.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.97e-06	3.32e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.97e-06	3.32e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.96e-06	3.31e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.95e-06	3.3e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.94e-06	3.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-06	3.28e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.93e-06	3.28e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.92e-06	3.26e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.89e-06	3.24e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	3.22e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.85e-06	3.18e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.82e-06	3.16e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	3.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.78e-06	3.11e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.74e-06	3.07e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.74e-06	3.06e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.73e-06	3.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.72e-06	3.04e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	3.02e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.7e-06	3.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.66e-06	2.97e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.66e-06	2.97e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.65e-06	2.96e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.64e-06	2.95e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.62e-06	2.93e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.6e-06	2.9e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	2.9e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.59e-06	2.89e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.59e-06	2.89e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.57e-06	2.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.56e-06	2.86e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.56e-06	2.86e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.55e-06	2.85e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.54e-06	2.84e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.53e-06	2.83e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.53e-06	2.83e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—INS—type 2 diabetes mellitus	2.52e-06	2.82e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.51e-06	2.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.47e-06	2.76e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.42e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.42e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.42e-06	2.7e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-06	2.67e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.32e-06	2.6e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	2.58e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.26e-06	2.53e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-06	2.52e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-06	2.49e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-06	2.49e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-06	2.47e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-06	2.47e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.21e-06	2.47e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	2.35e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.09e-06	2.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.09e-06	2.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.08e-06	2.32e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	2.32e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	2.31e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.05e-06	2.29e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-06	2.27e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.03e-06	2.27e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	2.26e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.99e-06	2.23e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.98e-06	2.22e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.98e-06	2.22e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.94e-06	2.17e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.94e-06	2.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.94e-06	2.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.9e-06	2.13e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	2.12e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.86e-06	2.08e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.85e-06	2.07e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	2.03e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	2.02e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	2.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.81e-06	2.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.78e-06	1.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	1.98e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.71e-06	1.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.68e-06	1.88e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.85e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	1.84e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.63e-06	1.82e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.6e-06	1.79e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.59e-06	1.78e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-06	1.76e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.39e-06	1.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.36e-06	1.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.25e-06	1.4e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-06	1.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-06	1.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	1.22e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	1.14e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	1.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.12e-07	1.02e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.91e-07	9.96e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.32e-07	9.3e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.49e-07	6.14e-06	CbGpPWpGaD
